We represented a large national healthcare company in its defense of a FCA qui tam involving its wholly-owned Pharmacy Benefit Manager.  After extensive negotiation, DOJ declined to intervene in the matter.  The relator pursued the case independently, which resulted in a favorable resolution to our client.